The Valley Desk

NCT02263508 · Interventional trial

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

Overall registry status Terminated

Phase 3

Conditions Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov